Cargando…
Nanoformulation of Geranylgeranyltransferase-I Inhibitors for Cancer Therapy: Liposomal Encapsulation and pH-Dependent Delivery to Cancer Cells
Small molecule inhibitors against protein geranylgeranyltransferase-I such as P61A6 have been shown to inhibit proliferation of a variety of human cancer cells and exhibit antitumor activity in mouse models. Development of these inhibitors could be dramatically accelerated by conferring tumor target...
Autores principales: | Lu, Jie, Yoshimura, Kohei, Goto, Koichi, Lee, Craig, Hamura, Ken, Kwon, Ohyun, Tamanoi, Fuyuhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4564137/ https://www.ncbi.nlm.nih.gov/pubmed/26352258 http://dx.doi.org/10.1371/journal.pone.0137595 |
Ejemplares similares
-
Identification and Characterization of Mechanism of Action of P61-E7, a Novel Phosphine Catalysis-Based Inhibitor of Geranylgeranyltransferase-I
por: Chan, Lai N., et al.
Publicado: (2011) -
In vitro and in vivo effects of geranylgeranyltransferase I inhibitor P61A6 on non-small cell lung cancer cells
por: Zimonjic, Drazen B, et al.
Publicado: (2013) -
The Optimized Delivery of Triterpenes by Liposomal Nanoformulations: Overcoming the Challenges
por: Milan, Andreea, et al.
Publicado: (2022) -
Synergistic Effect of Geranylgeranyltransferase Inhibitor, GGTI, and Docetaxel on the Growth of Prostate Cancer Cells
por: Han, Bin, et al.
Publicado: (2012) -
Geranylgeranyltransferase I is essential for dendritic development of cerebellar Purkinje cells
por: Wu, Kong-Yan, et al.
Publicado: (2010)